本所誠徵所長

國立陽明交通大學臨床醫學研究所成立於民國七十五年三月,現有博士班、碩士班及碩士在職專班,目前招生對象主要為醫師及對生命科學有興趣之非醫師學生。本所在學學生人數約149名、專任教師11名、合聘教師19名、兼任教師25名。

本所宗旨:培育能以疾病研究為導向從事轉譯醫學研究的科學家。

教育目標:博士班需具備獨立進行深入的機轉性研究及設計實驗的能力。碩士班為培養基本的研究能力、能學習各種實驗技能及研究方法。

本所首任所長由姜必寧教授擔任,歷經余家利教授、林幸榮教授、吳肇卿教授、謝世良教授、周德盈教授、王錦鈿教授後,目前欲徵聘新任所長。

敬邀副教授以上有興趣及能力者報名參選,報名者請依下列規定,於截止日前繳交報名表件至本所。經本所所長遴選委員會初步資料審核通過者,將再通知參加面談。

報名截止日期: 即日起至2024年06月20日止。
參選資格: 參選人需具副教授(含)以上資格。
參選方式: 參選方式可為個人報名或者由他人推薦(若為他人推薦,則須檢附個人參選同意書)。本委員會委員不得擔任推薦人及候選人。
參選人應檢附資料: 治所理念、個人簡歷、著作目錄、代表作10篇、參選人申請表須本人簽名、參選人需檢附兩封推薦函。(以上資料請繳交電子檔)
報名及資料繳交地址: (可E-Mail繳交電子檔)
886 台灣 11221 台北市北投區立農街二段155號 國立陽明交通大學臨床醫學研究所收
本所網址: https://icm.nycu.edu.tw/
本所聯絡人及聯絡方式: 小姐 E-Mail : yclin2@nycu.edu.tw

113學年度下學期專題討論可以開始預約囉!

各位臨醫所碩博士生您好:

113學年度下學期專題討論可以開始預約囉! 有確定要修的同學現在就可以與指導教授討論選文章囉! (已修讀過2次專題討論者,請勿預約.已經預約的也請不要重複填喔!)

請於2024/6/30日前上網填寫預約。

預約網址:  

https://forms.gle/Udvn5v84n2ff7Sk87

2024/7/3(星期三)下午3:00視訊抽籤決定每位同學的報告日期及順序喔!

壹、注意事項:

一、抽籤方式為依日期順序抽籤,當日抽籤完會E-Mail公布結果。

二、若對於抽籤結果產生的報告日期不滿意或因故無法配合者,請自行找其他時段同學更換報告日期,更換後一定要告知所辦喔!

三、有先預約的同學,請記得也要至選課系統選課喔!

四、沒有先預約者,若屆時無空堂則無法讓您修讀喔!

貳、專題討論報告文章選讀規定:

一、專題討論課程請和指導教授商議後,選擇一篇頂尖之近2年文章作為報告文章,若為臨床文章則應顧及大家共同的興趣,且報告者的表達須清晰明瞭,使非醫師的學生亦可以瞭解臨床的文章。本所專題討論負責教師擁有課程主導權,審定文章後若有不合者,將退件再請學生與指導教授重選文章。

與指導教授討論後選定之文章請於2024/7/31(三)前繳交,以便給負責教師審查。

2024/7/31(三)前要繳交的如下:

1、文章篇名(書寫格式請以Vancouver style的方式書寫,請詳閱以下第七點說明)

2、電子檔全文PDF檔案。

二、先抽講序只是為便利大家先準備報告,記得開學於選課系統仍要至校務行政系統選課喔!

三、每次上課的主持人由學生主持,課表屆時會排定每週的主持人。

四、碩士(專)班上課時段為星期四上午10:10~12:00教室預計於404教室。

  博士班上課時段為星期四下午3:30~6:00預計於405教室(每次都會點名)。

五、博士班請全程用英文報告,碩士班則依選課課名(一次中文,一次英文)。

六、學生報告時間為35分鐘,問問題20分鐘,每名講者中間下課休息5分鐘。(以按鈴計時)

七、Vancouver style書寫格式說明:

1. List all references in order by number, not alphabetically.

2. List all authors, but if the number exceeds six, give the first six followed by “et al.”

3. List the abbreviated journal title, period, year, volume, and page range。)

參考範例:

1. Wu TJ, Ong JJC ,Chang CM. Pulmonary veins and ligament of Marshall as sources of rapid activations in a canine model of sustained atrial fibrillation . Circulation 2001; 103:1157-63.

2. Lin JC, Jan JS, Hsu CY. Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: Positive effect on overall and progression-free survival. J Clin Oncol 2003; 21: 631-7.

3. Chen YJ, Chen SA, Chang MS. Arrhythmogenic activity of cardiac muscle in pulmonary veins of the dog: implication for the genesis of atrial fibrillation . Cardiovasc Res 2000; 48: 265-73.

4. Wu JC, Choo KB, Chen CM, Chen TZ, Huo TI, Lee SD. Genotyping of hepatitis D virus by restriction fragment length polymorphism and its correlation with outcomes of hepatitis D. Lancet 1995; 346: 939-41 .

5. Feng AN, Chen YL, Chen YT, Ding YZ, Lin SJ. Red wine inhibits MCP-1 expression and modestly reduces neointimal hyperplasia following balloon injury in cholesterol-fed rabbits. Circulation 1999;100:2254-9.

6. Niu DM, Hwang B, Chu YK, Liao CJ, Wang PL, Lin CY. High prevalence of a novel mutation (2268 insT) of the thyroid peroxidase gene in Taiwanese patients with total iodide organification defect, and evidence for a founder effect. J Clin Endocrinol Metab 2002; 87: 4208-12.

7 Yang MH, Chiang WC, Chou TY, Chang SY, Chen PM, Teng SC, et al. Increased NBS1 expression is a marker of aggressive head and neck cancer and overexpression of NBS1 contributes to transformation. Clin Cancer Res 2006; 12: 507-15.

RESEARCH HIGHLIGHTS

Shang F, Wang SC, Gongol B, Han SY, Cho Y, Schiavon CR, et al. Obstructive Sleep Apnea-induced Endothelial Dysfunction Is Mediated by miR-210. American journal of respiratory and critical care medicine. 2023;207(3):323-35.

Hung YW, Lee IC, Chi CT, Lee RC, Liu CA, Chiu NC, Hwang HE, Chao Y, Hou MC, Huang YH*. Radiologic Patterns Determine the Outcomes of Initial and Subsequent Transarterial Chemoembolization in Intermediate-Stage Hepatocellular Carcinoma. Liver Cancer. 2023 DOI: 10.1159/000530950 Published online: May 15, 2023 (*corresponding author) IF 12.43

Yang CY, Wu BS, Wang YF, Wu Lee YH, Tarng DC. Weight-Based Assessment of Access Flow Threshold to Predict Arteriovenous Fistula Functional Patency. Kidney international reports. 2022;7(3):507-15.

Chou JM, Tsai JL, Hung JN, Chen IH, Chen ST, Tsai MH. The ORF8 Protein of SARS-CoV-2 Modulates the Spike Protein and Its Implications in Viral Transmission. Frontiers in microbiology. 2022;13:883597.

Chen SP, Wang SJ. Pathophysiology of reversible cerebral vasoconstriction syndrome. Journal of biomedical science. 2022;29(1):72.

Chou PC, Liu CM, Weng CH, Yang KC, Cheng ML, Lin YC, et al. Fibroblasts Drive Metabolic Reprogramming in Pacemaker Cardiomyocytes. Circulation research. 2022;131(1):6-20.https://pubmed.ncbi.nlm.nih.gov/35611699https://pubmed.ncbi.nlm.nih.gov/35611699//

Chen SP, Hsu CL, Wang YF, Yang FC, Chen TH, Huang JH, et al. Genome-wide analyses identify novel risk loci for cluster headache in Han Chinese residing in Taiwan. The journal of headache and pain. 2022;23(1):147.

Qi RB, Wu ZH. Association between COVID-19 and chronic liver disease: Mechanism, diagnosis, damage, and treatment. World journal of virology. 2023;12(1):22-9.

Lee CW, Chen YF, Hsiao AW, Wang AY, Shen OY, Wang BY, et al. Demystifying the long noncoding RNA landscape of small EVs derived from human mesenchymal stromal cells. Journal of advanced research. 2022;39:73-88.

Wu CH, Lirng JF, Ling YH, Wang YF, Wu HM, Fuh JL, Lin PC, Wang SJ, Chen SP. Noninvasive characterization of human glymphatics and meningeal lymphatics in an in vivo model of blood-brain barrier leakage. Annals of Neurology 2021;89:111–124 (*Equal contribution)
Chen SP, Chang YA, Chou CH, Juan CC, Lee HC, Chen LK, Wu PC, Wang YF, Fuh JL, Lirng JF, Ducros A, Huang HD, Wang SJ. Circulating microRNAs associated with Reversible Cerebral Vasoconstriction Syndrome. Annals of Neurology 2021;89:459–473
 Lee ZF, Huang TH, Chen SP*, Cheng IH*. Altered nociception in Alzheimer disease is associated with striatal-enriched protein tyrosine phosphatase signaling. Pain 2021 Jun 1;162(6):1669-1680. (*Equal contribution)
Ling YH, Wang YF, Lirng JF, Fuh JL, Wang SJ, Chen SP*. Post-reversible cerebral vasoconstriction syndrome headache. The Journal of Headache and Pain. 2021; 22(1): 1-8
Lin PT, Wang YF, Fuh JL, Lirng JF, Ling YH, Chen SP*, Wang SJ*. Diagnosis and Classification of Headache Associated with Sexual Activity Using a Composite Algorithm: a cohort study. Cephalalgia 2021 Dec;41(14):1447-1457 (*Equal contribution)
Tsao YC, Wang SJ, Hsu CL, Wang YF, Fuh JL, Chen SP, Fann CSJ. Genome-wide association study reveals susceptibility loci for self-reported headache in a large community-based Asian population Cephalalgia 2021 in press. (*Equal contribution)
Wu CH, Wu HM, Ling YH, Wang YF, Fuh JL, Lin CJ, Ling K, Lirng JF, Wang SJ, Chen SP. Blood brain barrier permeability in patients with reversible cerebral vasoconstriction syndrome assessed with dynamic contrast-enhanced MRI. Neurology 2021 Nov 2;97(18):e1847-e1859. (*Equal contribution)
Liao SF, Koshiol J, Huang YH, Jackson SS, Huang YH, Chan C, Huang C, Liu PC, Chen YJ, Hsieh R, Huang JB, Lu SN, Chen CJ, Shen CY, Lee MH*. Postdiagnosis aspirin use associated with biliary tract cancer-specific mortality in a large nationwide cohort. Hepatology. 2021; 74 (4): 1994-2006 (IF=17.4)
Lee IC, Huang JY, Chen TC, Yen CH, Chiu NC, Hwang HE, Huang JG, Liu CA, Chau GY, Lee RC, Hung YP, Chao Y, Ho SY*, Huang YH*. Evolutionary Learning Derived Clinical-Radiomic Models for Predicting Early Recurrence of Hepatocellular Carcinoma After Resection. Liver Cancer 2021 on line fist; DOI: 10.1159/000518728 (*corresponding author, IF 11.74) 
Chi CT, Lee IC, Lee RC, Hung YW, Su CW, Hou MC, et al. Effect of Transarterial Chemoembolization on ALBI Grade in Intermediate-Stage Hepatocellular Carcinoma: Criteria for Unsuitable Cases Selection. Cancers. 2021;13(17).
Hung YW, Lee IC*, Chi CT, Lee RC, Liu CA, Chiu NC, Hwang HE, Chao Y, Hou MC,  Huang YH*. Redefining Tumor Burden in Patients with Intermediate Stage Hepatocellular Carcinoma: the Seven-Eleven Criteria. Liver Cancer 2021 Jul 23; DOI:10.1159/000517393. Online ahead of print. (IF 11.740)
Chen MHan*, Lee IC, Chen MHuang, Hou MC, Tsai CY, Huang YH*. Abatacept is second to rituximab at risk of HBsAg reverse seroconversion in patients with rheumatic disease. Annals of Rheumatic Diseases 2021 Jun 29:annrheumdis-2021-220774. doi: 10.1136/annrheumdis-2021-220774. Online ahead of print. (IF 19.103)
Chen KY, Huang YH*, Teo WH, Chang CW, Chen YS, Yeh YC, Lee CJ, Lo JF*. Loss of Tid1/DNAJA3 Co-chaperone Promotes Progression and Recurrence of Hepatocellular Carcinoma after Surgical Resection: a Novel Model to Stratify Risk of Recurrence. Cancers (Basel) 2021 Jan 4;13(1):138. 
Chen MHan, Chen MHuang, Chou CT, Hou MC, Tasi CY*, Huang YH*. Low but Long-lasting Risk of Reversal of Seroconversion in Patients With Rheumatoid Arthritis Receiving Immunosuppressive Therapy. Clin Gastroenterol Hepatol. 2020 Oct;18(11):2573–2581 (IF 11.382)
Lee PC, Chao Y, Chen MH, Lan KH, Lee IC, Hou MC, Huang YH*. Risk of HBV reactivation in patients with immune checkpoint inhibitor-treated unresectable hepatocellular carcinoma. J ImmunoTher Cancer 2020 Aug;8(2):e001072 (IF 13.751)
Chih-Yu Yang*, Pu-Yuan Chang, Jun-Yi Chen, Bo-Sheng Wu, An-Hang Yang, Oscar Kuang-Sheng Lee. Adipose-derived Mesenchymal Stem Cells Attenuate Dialysis-induced Peritoneal Fibrosis by Modulating Macrophage Polarization via Interleukin-6. Stem Cell Res. Ther. 2021 (In press).
Po-Yu Tseng, Yi-Ting Chen, Chuen-Heng Wang, Kuan-Ming Chiu, Yu-Sen Peng, Shih-Ping Hsu, Kang-Lung Chen, Chih-Yu Yang*, Oscar Kuang-Sheng Lee*. Prediction of the Development of Acute Kidney Injury Following Cardiac Surgery by Machine Learning. Crit Care. 2020 Jul 31;24(1):478.
Chih-Yu Yang, Jia-Sin Liu, Wei-Cheng Tseng, Ming-Tsun Tsai, Ming-Huang Lin, Zih-Kai Kao, Yao-Ping Lin, Chih-Cheng Hsu*, Der-Cherng Tarng*. Effect of Renin-Angiotensin-Aldosterone System Blockade on Long-term Outcomes in Post-Acute Kidney Injury Patients with Hypertension. Crit Care Med. 2020 Dec;48(12):e1185-e1193. 
Travis WD, Dacic S, Wistuba I, Sholl L, Adusumilli P, Bubendorf L, et al. IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2020.
Yalcin N, Chen SP, Yu ES, Liu TT, Yen JC, Atalay YB, et al. Caffeine does not affect susceptibility to cortical spreading depolarization in mice. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism. 2019;39(4):740-50.
Chen ST, Chen L, Lin DS, Chen SY, Tsao YP, Guo H, et al. NLRP12 Regulates Anti-viral RIG-I Activation via Interaction with TRIM25. Cell host & microbe. 2019;25(4):602-16.e7.
S.-C. Lin, C.-H. Chung, C.-H. Chung, M.-H. Kuo, C.-H. Hsieh, Y.-F. Chiu, Y.-S. Shieh, Y.-T. Chou, C.-W. Wu(2019)“OCT4B mediates hypoxia-induced cancer dissemination.”Oncogene.2019 Feb;38(7):1093-1105. doi: 10.1038/s41388-018-0487-6. Epub 2018 Sep 12.
Li CF, Chen JY, Ho YH, Hsu WH, Wu LC, Lan HY, Hsu DS, Tai SK, Chang YC, Yang MH*. Snail-induced claudin-11 prompts collective migration for tumour progression. Nat Cell Biol. 2019 Feb;21(2):251-262. (2018 IF=17.728)
Lu YW, Lu SF, Chou RH, Wu PS, Ku YC, Kuo CS, et al. Lipid paradox in patients with acute myocardial infarction: Potential impact of malnutrition. Clinical nutrition (Edinburgh, Scotland). 2019;38(5):2311-8.
Chen WT, Hsu WT, Yen MH, Changou CA, Han CL, Chen YJ, et al. Alteration of mesenchymal stem cells polarity by laminar shear stimulation promoting beta-catenin nuclear localization. Biomaterials. 2019;190-191:1-10.
Chu SY, Chou CH, Huang HD, Yen MH, Hong HC, Chao PH, et al. Mechanical stretch induces hair regeneration through the alternative activation of macrophages. Nature communications. 2019;10(1):1524.

個資保護及資訊安全宣告

一、 本所將遵守個人資料保護法(以下簡稱個資法)及其他相關法令規範,採取適切之個人資料保護暨資訊安全維護措施。
二、 本所之所務運作,將尊重當事人之權益,依誠實及信用方法,以合理合法安全之方式,於特定目的範圍內蒐集、處理或利用個人資料;如須為特定目的外之利用時,應告知並取得當事人之書面同意。
三、 本所將盡力維護當事人提供之個人資料為正確且最新之狀態,並避免個人資料被竊取、洩漏、竄改或受到其他侵害,同時加強本系相關設備安全及採取必要之防護措施,以保護所蒐集、處理及利用之個人資料。
四、 本所將尊重當事人對其個人資料所行使之權利,包括查詢或請求閱覽、請求製給複製本、請求補充或更正、請求停止蒐集、處理或利用及請求刪除,並依個資法相關規定迅速回應當事人。
五、 本所將致力提升個人資料保護之安全意識與強化各項資訊安全管理措施,每年不定期參與校方個人資料保護與資訊安全之教育訓練、認知宣導與資訊安全檢核。
六、 本所遵守校方個人資料保護與資訊安全管理相關作業規範,持續發展及實施個人資料保護管理工作,以確保政策得以落實。
七、 本所於委託蒐集、處理及利用個人資料時,應妥善監督受託單位,明訂個人資料安全保護責任及保密等規定,並列入契約,要求受託單位遵守並定期予以查核

網站資訊開放宣告

一、授權方式及範圍:

為利各界廣為利用網站資料,國立陽明交通大學醫學系網站上刊載之所有資料與素材,其得受著作權保護之範圍,以無償、非專屬,得再授權之方式提供公眾使用,使用者得不限時間及地域,重製、改作、編輯、公開傳輸或為其他方式之利用,開發各種產品或服務(簡稱加值衍生物),此一授權行為不會嗣後撤回,使用者亦無須取得本機關之書面或其他方式授權;然使用時,應註明出處。

二、相關事項說明:

(一)本授權範圍僅及於著作權保護之範圍,不及於其他智慧財產權利,包括但不限於專利、商標及機關標誌之提供。

(二)當事人自行公開或依法令公開之個人資料是否得被蒐集、處理及利用,使用者須自行依照個人資料保護法之相關規定,規劃並執行法律要求之相應措施。

(三)部分的影音、圖像、樂譜、專人專案撰文或其他著作,經機關特別聲明須經同意方可使用者。

三、應注意不得侵害第三人之著作人格權(包括姓名表示權及禁止不當變更權)。

四、使用本授權提供之資料與素材,不得惡意變更其相關資訊,若利用後所展示之資訊與原資料與素材不符,使用者須自負民事、刑事上之法律責任。

五、本網站之授權,並不授予使用者代表本機關建議、認可或贊同其加值衍生物之地位。